 | • レポートコード：MRC2206A022 • 出版社/出版日：Persistence Market Research / 2022年3月28日 • レポート形態：英文、PDF、257ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Enterprisewide | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査レポートでは、世界のライフサイエンス支出総額市場について広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症による危機分析、需要分析・予測、ソリューション別（第三者エンゲージメントソリューション、総支出報告ソリューション、社内ソフトウェアシステム、スプレッドシート使用手作業）分析、展開別(Webベース、クラウドベース)分析、ビジネス別（小規模ビジネス、中規模ビジネス、大企業）分析、エンドユーザー別（製薬会社、医療機器メーカー、バイオテクノロジー＆ライフサイエンス会社、医療施設）分析、地域別分析、市場構造分析、競争分析、仮定、調査手法などの項目を掲載しております。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・主要成功要因 ・市場背景 ・新型コロナウイルス感染症による危機分析 ・需要分析・予測 ・世界のライフサイエンス支出総額市場規模：ソリューション別（第三者エンゲージメントソリューション、総支出報告ソリューション、社内ソフトウェアシステム、スプレッドシート使用手作業） ・世界のライフサイエンス支出総額市場規模：展開別(Webベース、クラウドベース) ・世界のライフサイエンス支出総額市場規模：ビジネス別（小規模ビジネス、中規模ビジネス、大企業） ・世界のライフサイエンス支出総額市場規模：エンドユーザー別（製薬会社、医療機器メーカー、バイオテクノロジー＆ライフサイエンス会社、医療施設） ・世界のライフサイエンス支出総額市場規模：地域別 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
Life Sciences Aggregate-Spending Market: Scope of Report
The latest publication by Persistence Market Research on the global life sciences aggregate-spending market evaluates the opportunities and current market landscape, provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.
Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for life sciences aggregate-spending products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the life sciences aggregate-spending market. Shareholders in the life sciences aggregate-spending market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.
Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the life sciences aggregate-spending market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.
Key Market Segments
Persistence Market Research’s study on the life sciences aggregate-spending market offers information divided into five important segments – solution, deployment, business type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.
Solution
Third-party Engagement Solutions
Aggregate Spend Reporting Solutions
In-house Software Systems
Manually with Spreadsheets
Deployment
Web-based Deployment
Cloud-based Deployment
Business Type
Small Businesses
Medium Businesses
Large Enterprises
End User
Pharmaceutical Companies
Medical Devices Manufacturers
Biotechnology & Life-sciences Companies
Healthcare Settings
Region
North America
Europe
APAC
ROW
Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for life sciences aggregate-spending over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the life sciences aggregate-spending industry avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the life sciences aggregate-spending market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the life sciences aggregate-spending market are more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Roadmap for regulations
1.3. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Key Success Factors
4.1. Unmet Needs
4.2. Regulatory Considerations for Life Sciences Aggregate-Spending
4.3. Key Promotional & G-to-Market Strategies, By Solution Providers
4.4. Key Deals and Contracts
4.5. End User Survey Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare IT Expenditure Outlook
5.1.3. Ratio of Spending in aggregate spend and transparency reporting
5.2. Forecast Factors – Relevance & Impact
5.2.1. GDP Growth
5.2.2. Top Companies Historical Growth
5.2.3. Evolving Regulatory Policies
5.2.4. Awareness amongst Healthcare Professionals
5.2.5. Adoption of transparency reporting laws in the US states
5.2.6. Global adoption of Sunshine law-like regulations
5.3. Value Chain Analysis
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current perspectives on the coronavirus outbreak
6.2. Current COVID-19 Statistics and Probable Future Impact
6.3. Current GDP Projection and Probable Impact
6.4. Impact of COVID-19 on the Global Life Sciences Aggregate-Spending Market
7. Global Life Sciences Aggregate-Spending Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
7.1. Introduction/Key Findings
7.2. Historical Market Value (US$ Mn) Analysis, 2017-2021
7.3. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.3.1. Y-o-Y Growth Trend Analysis
7.3.2. Absolute $ Opportunity Analysis
8. Global Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032, by Solution
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Solution, 2017-2021
8.3. Current and Future Market Size (US$ Mn) Forecast By Solution, 2022-2032
8.3.1. Third Party Engagement Solutions
8.3.2. Aggregate Spend Reporting Solutions
8.3.3. In-house software Systems
8.3.4. Manually with spreadsheets
8.4. Market Attractiveness Analysis By Solution
9. Global Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032, by Deployment
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Deployment, 2017-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Deployment, 2022-2032
9.3.1. Web-based Deployment
9.3.2. Cloud based Deployment
9.4. Market Attractiveness Analysis By Deployment
10. Global Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032, by Business
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Deployment, 2017-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Deployment, 2022-2032
10.3.1. Small Business
10.3.2. Medium Business
10.3.3. Large Enterprise
10.4. Market Attractiveness Analysis By Business
11. Global Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
11.3.1. Pharmaceutical Companies
11.3.2. Medical Device Manufacturers
11.3.3. Biotechnology & Life Sciencess Companies
11.3.4. Healthcare Settings
11.4. Market Attractiveness Analysis By End User
12. Global Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Europe
12.3.3. APAC
12.3.4. Rest of the World
12.4. Market Attractiveness Analysis By Region
13. North America Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Market Snapshot
13.2. Introduction
13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.2. By Solution
13.4.3. By Deployment
13.4.4. By Business
13.4.5. By End User
13.5. Market Attractiveness Analysis
14. Europe Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Market Snapshot
14.2. Introduction
14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. U.K.
14.4.1.2. Germany
14.4.1.3. Italy
14.4.1.4. France
14.4.1.5. Spain
14.4.1.6. Rest of Europe
14.4.2. By Solution
14.4.3. By Deployment
14.4.4. By Business
14.4.5. By End User
14.5. Market Attractiveness Analysis
15. APAC Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Market Snapshot
15.2. Introduction
15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. India
15.4.1.2. Japan
15.4.1.3. Australia
15.4.1.4. South Korea
15.4.1.5. Rest of APAC
15.4.2. By Solution
15.4.3. By Deployment
15.4.4. By Business
15.4.5. By End User
15.5. Market Attractiveness Analysis
16. ROW Life Sciences Aggregate-Spending Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Market Snapshot
16.2. Introduction
16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Brazil
16.4.1.2. Saudi Arabia
16.4.1.3. Rest of the World
16.4.2. By Solution
16.4.3. By Deployment
16.4.4. By Business
16.4.5. By End User
16.5. Market Attractiveness Analysis
17. Country Wise Life Sciences Aggregate-Spending Market Analysis 2022 & 2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. U.S. Life Sciences Aggregate-Spending Market Analysis
17.2.1. By Solution
17.2.2. By Deployment
17.2.3. By Business
17.2.4. By End User
17.3. Canada Life Sciences Aggregate-Spending Market Analysis
17.3.1. By Solution
17.3.2. By Deployment
17.3.3. By Business
17.3.4. By End User
17.4. U.K. Life Sciences Aggregate-Spending Market Analysis
17.4.1. By Solution
17.4.2. By Deployment
17.4.3. By Business
17.4.4. By End User
17.5. Germany Life Sciences Aggregate-Spending Market Analysis
17.5.1. By Solution
17.5.2. By Deployment
17.5.3. By Business
17.5.4. By End User
17.6. France Life Sciences Aggregate-Spending Market Analysis
17.6.1. By Solution
17.6.2. By Deployment
17.6.3. By Business
17.6.4. By End User
17.7. Italy Life Sciences Aggregate-Spending Market Analysis
17.7.1. By Solution
17.7.2. By Deployment
17.7.3. By Business
17.7.4. By End User
17.8. Spain Life Sciences Aggregate-Spending Market Analysis
17.8.1. By Solution
17.8.2. By Deployment
17.8.3. By Business
17.8.4. By End User
17.9. India Life Sciences Aggregate-Spending Market Analysis
17.9.1. By Solution
17.9.2. By Deployment
17.9.3. By Business
17.9.4. By End User
17.10. Japan Life Sciences Aggregate-Spending Market Analysis
17.10.1. By Solution
17.10.2. By Deployment
17.10.3. By Business
17.10.4. By End User
17.11. Australia Life Sciences Aggregate-Spending Market Analysis
17.11.1. By Solution
17.11.2. By Deployment
17.11.3. By Business
17.11.4. By End User
17.12. South Korea Life Sciences Aggregate-Spending Market Analysis
17.12.1. By Solution
17.12.2. By Deployment
17.12.3. By Business
17.12.4. By End User
17.13. Brazil Life Sciences Aggregate-Spending Market Analysis
17.13.1. By Solution
17.13.2. By Deployment
17.13.3. By Business
17.13.4. By End User
17.14. Saudi Arabia Life Sciences Aggregate-Spending Market Analysis
17.14.1. By Solution
17.14.2. By Deployment
17.14.3. By Business
17.14.4. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Qordata
19.2.1.1. Overview
19.2.1.2. Product Portfolio
19.2.1.3. Key Financials
19.2.1.4. SWOT Analysis
19.2.1.5. Strategy Overview
19.2.2. Porzio Life Sciencess LLC
19.2.2.1. Overview
19.2.2.2. Product Portfolio
19.2.2.3. Key Financials
19.2.2.4. SWOT Analysis
19.2.2.5. Strategy Overview
19.2.3. MedPro Systems® LLC.
19.2.3.1. Overview
19.2.3.2. Product Portfolio
19.2.3.3. Key Financials
19.2.3.4. SWOT Analysis
19.2.3.5. Strategy Overview
19.2.4. Pharmagin
19.2.4.1. Overview
19.2.4.2. Product Portfolio
19.2.4.3. Key Financials
19.2.4.4. SWOT Analysis
19.2.4.5. Strategy Overview
19.2.5. IQVIA
19.2.5.1. Overview
19.2.5.2. Product Portfolio
19.2.5.3. Key Financials
19.2.5.4. SWOT Analysis
19.2.5.5. Strategy Overview
19.2.6. Vector Health Inc.
19.2.6.1. Overview
19.2.6.2. Product Portfolio
19.2.6.3. Key Financials
19.2.6.4. SWOT Analysis
19.2.6.5. Strategy Overview
19.2.7. Alanda Software LLC
19.2.7.1. Overview
19.2.7.2. Product Portfolio
19.2.7.3. Key Financials
19.2.7.4. SWOT Analysis
19.2.7.5. Strategy Overview
19.2.8. MediCompli
19.2.8.1. Overview
19.2.8.2. Product Portfolio
19.2.8.3. Key Financials
19.2.8.4. SWOT Analysis
19.2.8.5. Strategy Overview
19.2.9. Capgemini
19.2.9.1. Overview
19.2.9.2. Product Portfolio
19.2.9.3. Key Financials
19.2.9.4. SWOT Analysis
19.2.9.5. Strategy Overview
19.2.10. MMIS Inc.
19.2.10.1. Overview
19.2.10.2. Product Portfolio
19.2.10.3. Key Financials
19.2.10.4. SWOT Analysis
19.2.10.5. Strategy Overview
19.2.11. Cerner Corporation
19.2.11.1. Overview
19.2.11.2. Product Portfolio
19.2.11.3. Key Financials
19.2.11.4. SWOT Analysis
19.2.11.5. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Table 01: Global Life Sciences Aggregate-Spending Market Demand (US$ Mn) Analysis 2017– 2021 and Forecast 2022–2032, By SolutionTable 02: Global Life Sciences Aggregate-Spending Market Demand (US$ Mn) Analysis 2017– 2021 and Forecast 2022–2032, By Deployment
Table 03: Global Life Sciences Aggregate-Spending Market Demand (US$ Mn) Analysis 2017– 2021 and Forecast 2022–2032, By Business
Table 04: Global Life Sciences Aggregate-Spending Market Demand (US$ Mn) Analysis 2017– 2021 and Forecast 2022–2032, By End-User
Table 05: Global Life Sciences Aggregate-Spending Market Demand (US$ Mn) Analysis 2017– 2021 and Forecast 2022–2032, By Region
Table 06: North America Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 07: North America Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Solution
Table 08: North America Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Deployment
Table 09: North America Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Business Type
Table 10: North America Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 11: Europe Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 12: Europe Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Solution
Table 13: Europe Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Deployment
Table 14: Europe Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Business Type
Table 15: Europe Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 16: APAC Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 17: APAC Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Solution
Table 18: APAC Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Deployment
Table 19: APAC Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Business Type
Table 20: APAC Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 21: ROW Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Region
Table 22: ROW Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Solution
Table 23: ROW Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Deployment
Table 24: ROW Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Business Type
Table 25: ROW Life Sciences Aggregate-Spending Market Size (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User